Arcus Biosciences
RCUS
RCUS
185 hedge funds and large institutions have $812M invested in Arcus Biosciences in 2025 Q2 according to their latest regulatory filings, with 26 funds opening new positions, 85 increasing their positions, 49 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% more first-time investments, than exits
New positions opened: 26 | Existing positions closed: 26
1% less funds holding
Funds holding: 186 → 185 (-1)
Holders
185
Holding in Top 10
1
Calls
$26.4M
Puts
$1.52M
Top Buyers
| 1 | +$25.2M | |
| 2 | +$9.18M | |
| 3 | +$5.56M | |
| 4 |
BlackRock
New York
|
+$4.81M |
| 5 |
Jane Street
New York
|
+$3.07M |
Top Sellers
| 1 | -$15.3M | |
| 2 | -$9.18M | |
| 3 | -$5.01M | |
| 4 |
Millennium Management
New York
|
-$3.37M |
| 5 |
DC
Decheng Capital
Menlo Park,
California
|
-$3.29M |
